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Tuesday, February 10, 2015 349athe water; water structure largely controls interaction of ions with one another
and with the protein. We had previously posited that there must be an oscil-
lating gate including water, which changes structure with ion position (Int’l J.
Molec. Struct., 2012, 13, 1680); newly calculated structures correspond to the
previously hypothetical states. These results also indicate the presence of two
other local minima for the ion, one in the cavity, one at the entrance to the
selectivity filter, where the protein replaces water in solvating the ion. A sin-
gle ion there is sufficiently distant that the gate water cluster returns to its
original form. There is some charge transfer to the ion from unshared electron
pairs on oxygen. Finally, we determine the water cluster structure’s relation
to boundary protein. The water column in the pore is continuous, and energy
barriers for an ion moving up in the pore appear compatible with observed
conductivity in the channel. Thus, interactions between ions are largely
modulated by water structure interacting with protein structure, not simply
electrostatics.
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Calmodulin (CaM) availability regulates neuronal excitability by controlling
the functional density of the potassium voltage-dependent M-current, but the
basis of this fundamental process is not well understood. We have examined
the consequences of varying CaM levels on the main constituents of the M-cur-
rent, which are Kv7.2 and Kv7.3 subunits. We found that CaM increased the
functional density of Kv7.2 channels but not that of Kv7.2/3 or Kv7.3. Similar
effects were also observed with a mutant CaM unable to bind Ca2þ. In agree-
ment with the proposed role in trafficking, CaM augmented the number
of channels at the plasma membrane. To address the involvement of PIP2,
its abundance was transiently reduced by activating Danio rerio voltage-
sensitive phosphatase (Dr-VSP). CaM-dependent Kv7.2 current potentiation
was linked to increased resistance to PIP2 depletion. In contrast, sequestration
of endogenous CaM led to a reduction in the functional current density for the
three Kv7 channel combinations examined (2, 2/3 and 3). These results suggest
that CaM is affecting two mechanisms: one leads to an increase in the number
of channels at the plasma membrane, and the second involves a PIP2-dependent
increase in opening probability
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The IKs current controls action potential duration in the heart, and abnormal
function of this current causes cardiac arrhythmias. The IKs current is carried
by the voltage activated KCNQ1 potassium channel associated with KCNE1
b-subunits. 18 years of study have shown that KCNE1 drastically modulates
every characteristic of KCNQ1, such that it would appear as if KCNQ1 and
KCNQ1þ KCNE1 were completely unrelated channels. However, no
coherent mechanism has been provided that can explain all these drastic
changes, which are essential for the physiological role of IKs. Here we
show that KCNE1 alters the state-dependent interactions (coupling) between
the voltage-sensing and pore-gate domains of KCNQ1 and that this sole
mechanism is sufficient to explain all these changes. Contrary to conventional
belief that the voltage-sensing domain must reach the fully-activated state
before promoting pore-opening, we found that the KCNQ1 channels can
open when the voltage-sensing domain is at intermediate and fully-activated
states. Importantly, the intermediate-open and activated-open channels differ
in voltage-dependence, ion-permeation, pharmacology and dependence on
PIP2, a cofactor for coupling between the voltage-sensing and pore-gate do-
mains. By changing the coupling, KCNE1 prevents the intermediate-open
state and changes the properties of the activated-open state, thereby bringing
about the characteristics of the IKs current. These results indicate that, during
voltage-dependent ion channel gating, every-state of the voltage-sensingdomain along its activation pathway is coupled to the conformation of
the pore domain through a unique set of protein-protein and protein-lipid in-
teractions. These interactions determine both the open-probability and the
open-pore properties.
1754-Plat
Disruption of Assembly/Calmodulin-Binding Coupling and Calmodulin-
Dependent Potentiation of Kv7.2 Channels by a Epileptogenic Helix D
Mutation
Araitz Alberdi1, Ganeko Bernardo-Seisdedos1, Carolina Gomis-Perez1,
Alessandro Alaimo1, Covadonga Malo1, Elisabeth Butz2,
Christian Wahl-Schott2, Pilar Areso3, Alvaro Villarroel1.
1Unidad de Biofı´sica CSIC, UPV/EHU, Leioa, Spain, 2Zentrum fu¨r
Pharmaforschung - Ludwig-Maximilians-Universita¨t Mu¨nchen, Munich,
Germany, 3Pharmacology Department, UPV-EHU, Leioa, Spain.
Kv7.2 is a main component of the neuronal M-current, whose density de-
pends on the interaction with calmodulin (CaM). Several observations hint
that CaM binding is coupled to Kv7 subunit multimerization, but such
important process is not well-understood. Whereas subunit specific assembly
of Kv7 channels depends on helix D, CaM binds to helices A and B located
60 residues upstream. By studying the consequences of the helix D L609R
mutation found in patients suffering Neonatal Familial Seizures, we confirm
that helix D is crucial for C-terminal multimerization. Surprisingly, disrup-
tion of helix D-dependent C-terminal multimerization by L609R has no ma-
jor consequences for Kv7.2 channel electrophysiological properties. FRET
results suggest that CaM enhances multimerization of the wt C-terminal
domain, but has marginal effects when the helix D mutation is present.
The L609R mutation weakens the interaction with CaM and disrupts
CaM-dependent Kv7.2 potentiation. These results underscore a complex
interconnection between CaM, PIP2 and multimerization on the regulation
of homomeric Kv7.2 channels.
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Statins are among the most commonly prescribed drug classes, and their use is
expected to increase due to recent changes in therapy guidelines. Although
statins have been suggested to shorten QT interval in heart failure patients,
the effect of this drug class on cardiac electrophysiology has been incom-
pletely studied. Here we study the effect of statins on one of the major repo-
larizing currents in the heart, IKs. We show that in response to a known stress
stimulus (sustained alpha-AR stimulation), IKs undergoes clathrin-dependent
internalization. Statin treatment inhibits this internalization. Our results sug-
gest that statin regulates IKs internalization by inhibiting activation of
Rab5, a GTPase involved in endocytic pathway regulation. We observe no
significant effect of statin treatment on unstimulated IKs function and acute
receptor regulation. Our results suggest that statins may prevent pathological
QT prolongation in heart failure patients by inhibiting pathological remodel-
ing and IKs internalization, while maintaining physiological trafficking and
function of the channel.
Platform: Membrane Receptors and Signal
Transduction
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G protein-coupled receptors (GPCRs) function as sensory, synaptic and hor-
mone receptors. Metabotropic glutamate receptors (mGluRs) are dimeric class
C GPCRs that mediate synaptic transmission and plasticity, and serve as drug
targets for Parkinson’s disease, schizophrenia and autism. We developed an
assay based on single molecule Forster resonance energy transfer (smFRET)
to probe the conformational dynamics of full length mammalian group II
mGluRs. Our assay revealed the structural dynamics associated with the ligand
350a Tuesday, February 10, 2015binding and provided a dynamical basis for the efficacy of partial agonists or
full agonists, as well as the modulation of activation by positive allosteric mod-
ulators (PAMs). Finally, our work provides a general model for the activation
process of mGluRs.
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Biased agonism, that is the ligand-dependent selectivity for specific signaling
pathways in a G protein coupled receptor (GPCR), is an emerging, promising
strategy for the development of safer drugs. In the case of the kappa opioid re-
ceptor (KOPr), its preferential activation of G-protein versus b-arrestin has
been proposed to provide a more direct route to discovering non-addictive
opioid therapeutics with reduced side effects. In fact, the KOPr-mediated
dysphoria that usually accompanies the beneficial analgesic effect of KOPr
agonists has recently been attributed to the activation of the p38 mitogen-
activated protein kinase pathway, which is believed to follow arrestin recruit-
ment to the activated KOPr. This observation suggests that KOPr agonists
that selectively activate the G protein, but do not recruit arrestin, may be
more effective analgesics since they would not exhibit the adverse effects trig-
gered by the arrestin pathway.
Based on the above, understanding the structural and chemical determinants of
biased agonism at the KOPr is highly desirable as it can guide the discovery/
design of improved therapeutics. Here, we employ flexible docking of a set
of recently characterized functionally selective KOPr ligands to establish a pre-
dictive model for G protein-biased agonism at this receptor based on character-
istics of modes of interaction between the ligand and the KOPr. We apply the
resulting classifier to a large set of established KOPr agonists to assess their
ability to preferentially promote G protein coupling, arrestin recruitment, or
both.
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G protein-coupled receptors (GPCRs) are the integral membrane proteins that
detect extracellular ligands and mediate signal transduction. Binding of ligands
promotes transitions from inactive to active receptor conformations, which are
recognized by intracellular effectors. Chemically distinct ligands may trigger
different signaling responses by altering dynamics of the receptor. We devel-
oped a single-molecule fluorescence system to observe conformational switch-
ing of the b2-adrenergic receptor in real-time within a native-like membrane
environment. The receptor was covalently labeled with a photostable and
environmentally-responsive Cy3 fluorophore at the cytoplasmic end of either
transmembrane (TM) helix VI or helix VII. Individual receptor molecules
were incorporated in phospholipid nanodiscs, tethered to a microscope cover
slip and visualized over time by total internal reflection fluorescence micro-
scopy. We observed spontaneous transitions of TM helices VI and VII between
inactive and active conformations, even in the absence of any ligands. Studies
of ligands that span a comprehensive range of pharmacological efficacies
showed that full agonists shorten the time spent in the inactive conformations
and prolong the time in the active conformations, leading to an increased pop-
ulation of active species, while an inverse agonist prolonged the time spent in
inactive conformations. These observations provide new insights into the
mechanism of GPCR activation and the molecular basis for the variable phar-
macological efficacies of different drug molecules.
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G-protein-coupled receptor (GPCR) crystal structures reveal exquisite details
of interactions between amino acids and bound ligands. However, little isknown about the pathways by which ligands enter their binding sites. Binding
pathways are essential determinants of association and dissociation rates and
thus underlie kinetic selectivity, a phenomenon in which a ligand primarily
affects a particular receptor despite having similar binding affinity for several
closely related receptors. Protease-activated receptor 1 (PAR1) is a GPCR
whose endogenous agonist is a tethered, water-soluble peptide generated by
thrombin cleavage. By contrast, the PAR1-specific antagonist vorapaxar is a
lipophilic small molecule that binds in a pocket almost entirely occluded
from extracellular solvent.
Based on temperature-accelerated molecular dynamics simulations, we hypoth-
esize that vorapaxar enters the PAR1 binding pocket from the lipid bilayer be-
tween transmembrane helices 6 and 7 (TM6 and TM7). To test this hypothesis,
we take a chemical biology approach and synthesize vorapaxar derivatives with
alkyl chains extending along the predicted binding pathway. In cell signaling
assays, we find that the on-rate for vorapaxar derivatives with increased bulk
between TM6 and TM7 is no slower than that of vorapaxar. These data indicate
that vorapaxar likely enters the binding pocket from the lipid bilayer, through
the cleft between TM6 and TM7. While other groups have reported experi-
mental evidence that retinal binds to rhodopsin through a channel from the lipid
bilayer, our study provides the first such data for a ligand binding to a peptide
GPCR. Membrane drug entry mechanisms, such as the pathway we describe for
vorapaxar binding to PAR1, may be important for understanding kinetic selec-
tivity of lipophilic GPCR ligands and may inform selective drug design.
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TIRF microscopy allows us to visualize individual fluorophores in living cells.
We have developed automated algorithms to detect and track thousands of in-
dividual molecules and have studied GPCRs (G-protein coupled receptors)
tagged with fluorescent ligands or fluorescent proteins in live cultured cells
and freshly dissected tissue slices.
We have found that M1 and M2 muscarinic receptors diffuse freely at the
plasma membrane with their mobility dependent upon both cell-type and tem-
perature. The mobility of M2 receptors tagged with the fluorescent antagonist
(Cy3B-telenzepine) matches the mobility of M2-GFP molecules imaged under
the same conditions. Fluorophore tracking allowed direct observation of tran-
sient homo-dimerisation of M1 and M2 receptors which we confirmed using
two-color imaging. At a membrane receptor density of 2 mm2, 30% of recep-
tors were dimeric and the dimer lifetime was ~1 s1.
We have found that only ~10% of isolated primary cardiomyocytes and cells in
the mice heart slices expressed M2 receptors on the detectable level. The recep-
tors undergo unrestricted diffusion and therefore were evenly distributed across
the cell membrane. The M2 density in freshly isolated embryonic cardiomyo-
cytes was ~1 mm2, increasing at birth to ~3 mm2 and decreasing back to
~1 mm2 after birth. Whilst some M2 receptors formed reversible dimers the
majority were monomeric. The receptor mobility was approximately 4-times
faster in freshly dissected heart slices (0.6 mm2 s1) than in cultured primary
cardiomyocytes. Knowing receptor mobility and density we used Monte Carlo
simulations to estimate an encounter rate of 5-10 collisions per second. This
may explain the observed electrophysiological latency between the application
of acetylcholine and GIRK channel opening.
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The CD14 co-receptor is specialized for recognition of bacterial lipopolysac-
charide (LPS). On the surface of macrophages and other immune cells, it trans-
fers LPS and its bioactive component lipid A to the MD-2 protein in complex
with Toll-Like Receptor 4 (TLR4), and is hence crucial in activating the innate
immune system via the TLR4 signalling pathway. In the case of severe infec-
tions, lipid A can cause sepsis through over-activation of the immune
response, leading to multiple organ failure and death, and has become a major
target for anti-septic drugs. Unfortunately, the mechanism by which lipid A
is transferred to CD14, and the detailed mode(s) of associated binding, are
